Your browser doesn't support javascript.
loading
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
Ridker, Paul M; Bhatt, Deepak L; Pradhan, Aruna D; Glynn, Robert J; MacFadyen, Jean G; Nissen, Steven E.
Affiliation
  • Ridker PM; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: pridker@bwh.harvard.edu.
  • Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, NY, USA.
  • Pradhan AD; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Glynn RJ; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • MacFadyen JG; Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Nissen SE; Cleveland Clinic Heart and Vascular Institute, Cleveland, OH, USA.
Lancet ; 401(10384): 1293-1301, 2023 04 15.
Article in En | MEDLINE | ID: mdl-36893777
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Hyperlipidemias Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Year: 2023 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Atherosclerosis / Hyperlipidemias Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Year: 2023 Document type: Article Country of publication: United kingdom